4DMedical Limited
FDMDF
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.43B
Close$
Share Statistics
| Market cap | $2.43 Billion |
|---|---|
| Enterprise Value | $2.15 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.03 |
| Beta | 1.97 |
| Outstanding Shares | 597,328,000 |
Return
| Return on Equity | -137.93% |
|---|---|
| Return on Assets | -64.24% |
| Return on Invested Capital | -29.52% |
Valuation & Multiples
| P/E Ratio | -10.27 |
|---|---|
| PEG | -2.85 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 166.95 |
| Enterprise Value to EBIT | -20.54 |
| Enterprise Value to Net Income | -10 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 27, 2026
EPS Estimate
$-0.03
Average shareholder expectationRevenue Estimate
$5.24 M
Average shareholder expectationNext Earnings Call
Expected Date
February 26, 2027
EPS Estimate
$-0.02
Average shareholder expectationRevenue Estimate
$6.19 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About 4DMedical Limited
181 employees
CEO: Andreas Fouras Incorporated in 2012 and headquartered in Carlton, Australia, 4DMedical Limited operates as a medical technology enterprise across Australia and the United States. The company primarily focuses on bringing to market its innovative XV Tec...